Research Article
Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent
Table 3
Cumulative clinical outcomes up to 6 months.
| | In hospital (; 100%) | 30-day follow-up (; 100%) | 6-month follow-up (; 99.22%) |
| Death, (%) | 2 (0.8%) | 2 (0.8%) | 2 (0.8%) | Cardiac death, (%) | 2 (0.8%) | 2 (0.8%) | 2 (0.8%) | Noncardiac death, (%) | 0 (0%) | 0 (0%) | 0 (0%) | Myocardial infarction, (%) | 0 (0%) | 0 (0%) | 3 (1.2%) | Q-wave, (%) | 0 (0%) | 0 (0%) | 2 (0.8%) | Non-Q-wave, (%) | 0 (0%) | 0 (0%) | 1 (0.4%) | TLR, (%) | 0 (0%) | 0 (0%) | 0 (0%) | TVR, (%) | 0 (0%) | 0 (0%) | 0 (0%) | ST, (%) | 0 (0%) | 0 (0%) | 0 (0%) | Total | 2 (0.8%) | 2 (0.8%) | 5 (2.0%) |
|
|
TVR: target vessel revascularization; TLR: target lesion revascularization; ST: stent thrombosis.
|